We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBSB
426
DELISTED
Meridian Bancorp, Inc.
EBSB
| $3.3M | 0.05% |
184,590
+14,610
| +9% | +$250K |
|
427
Dropbox
DBX
$6.81B
| $3.28M | 0.05% |
130,836
-26,300
| -17% | -$608K |
|
|
TRUE
428
DELISTED
TrueCar
TRUE
| $3.28M | 0.05% |
600,087
+245,539
| +69% | +$1.51M |
|
429
InterDigital
IDCC
$6.68B
| $3.25M | 0.05% |
50,500
-75,362
| -60% | -$5.03M |
|
430
Amkor Technology
AMKR
$16.1B
| $3.19M | 0.04% |
427,337
+65,510
| +18% | +$513K |
|
|
MAGN
431
Magnera Corp
MAGN
$488M
| $3.18M | 0.04% |
14,493
+11,248
| +347% | +$2.24M |
|
432
VICI Properties
VICI
$29.4B
| $3.16M | 0.04% |
143,400
-743,602
| -84% | -$16.6M |
|
433
Independent Bank Corp
IBCP
$776M
| $3.14M | 0.04% |
144,094
-1,984
| -1% | -$43K |
|
434
Talos Energy
TALO
$2.49B
| $3.13M | 0.04% |
130,247
+73,413
| +129% | +$1.92M |
|
|
GTS
435
DELISTED
Triple-S Management Corporation
GTS
| $3.11M | 0.04% |
137,259
+86,529
| +171% | +$1.96M |
|
|
COR
436
DELISTED
Coresite Realty Corporation
COR
| $3.11M | 0.04% |
+27,020
| New | +$3.06M |
|
|
RVNC
437
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.1M | 0.04% |
+238,847
| New | +$3.01M |
|
|
WIRE
438
DELISTED
Encore Wire Corp
WIRE
| $3.09M | 0.04% |
52,739
+11,130
| +27% | +$622K |
|
|
CLR
439
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $3.09M | 0.04% |
73,320
-33,050
| -31% | -$1.41M |
|
|
VSTO
440
DELISTED
Vista Outdoor Inc.
VSTO
| $3.05M | 0.04% |
343,839
-133,822
| -28% | -$1.15M |
|
441
Koppers
KOP
$966M
| $3.05M | 0.04% |
103,811
+35,750
| +53% | +$996K |
|
442
H&R Block
HRB
$5.18B
| $3.04M | 0.04% |
+103,916
| New | +$2.79M |
|
443
Coherus Oncology
CHRS
$217M
| $3.04M | 0.04% |
137,591
+43,005
| +45% | +$747K |
|
444
Medifast
MED
$108M
| $3.04M | 0.04% |
+23,700
| New | +$3.29M |
|
|
RUTH
445
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $3.02M | 0.04% |
132,883
+91,899
| +224% | +$2.25M |
|
|
LMNX
446
DELISTED
Luminex Corp
LMNX
| $3.01M | 0.04% |
145,945
+31,802
| +28% | +$698K |
|
447
Element Solutions
ESI
$9.12B
| $3M | 0.04% |
+290,515
| New | +$3.06M |
|
448
Acuity Brands
AYI
$9.88B
| $3M | 0.04% |
21,773
-43,847
| -67% | -$6.03M |
|
449
Sterling Infrastructure
STRL
$20.3B
| $3M | 0.04% |
223,621
+32,650
| +17% | +$421K |
|
|
REGI
450
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.99M | 0.04% |
188,723
-180,123
| -49% | -$3.32M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.